| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-06 |
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | 0.15 | 3e-06 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0004 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0005 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0008 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.001 |
| mRNA | BMS-754807 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | -0.11 | 0.003 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |